Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

A new analysis of health insurance data indicates that more than 10 percent of women who chose medication abortion ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Milk not declared as an allergen was found in a Tennessee-based manufacturer's confectionery, not the first time candy has been recalled in the U.S. in 2025.

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

Missouri Sen. Josh Hawley issued a letter on Monday urging the U.S. Food and Drug Administration (FDA) to reinstate safety ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...